ARCHIVES

IOM, NCI Clash Over Proposed Change in Tabulating Minority Research

This article is from The Cancer Letter archive.

Vol. 25 No. 03 | January 22, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

In Brief: 896 Nurses Pass Oncology Certification Exam; ACS Awards 375 New Grants Worth $43.8 Million

July 6, 1990

Better Access Key To Higher Survival For African-Americans With Colon Cancer

August 30, 2002

AACI’s “12 Tasks” Outlined to Board

March 28, 1975

ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer

May 30, 2014